Lammintausta Kaija, Kortekangas-Savolainen Outi
Department of Dermatology, Turku University Central Hospital, Finland.
Acta Derm Venereol. 2005;85(6):491-6. doi: 10.1080/00015550510042859.
The aim of this study was to analyse the usefulness of oral challenge test with different drugs in confirming cutaneous adverse drug reactions in routine clinical practice. During the years 1975-2000 a total of 1,001 challenges were carried out in 784 patients. Patients with serious drug reactions were excluded and those with positive skin test reactions were challenged only in dubious cases. Of 1,001 challenges, 136 (13%) patients developed a positive challenge reaction. Antimicrobial drugs were most commonly suspected, accounting for 67% of challenges and 66% of the positive reactions. Exanthema was the most common skin reaction (72%), followed by fixed drug eruption (16%) and urticaria (12%). One serious challenge reaction with salazosulfapyridine was seen. We conclude that the challenge test is most useful as a tolerance test or to exclude drug hypersensitivity. It may be useful to complete studies of adverse drug reactions in patients with a history of exanthema, if other diagnostic methods are not available or if other diagnostic tests yield negative results. Out-patient protocol can be used in most cases.
本研究的目的是分析在常规临床实践中,使用不同药物进行口服激发试验在确诊皮肤药物不良反应方面的效用。在1975年至2000年期间,共对784例患者进行了1001次激发试验。严重药物反应患者被排除在外,只有在可疑病例中才对皮肤试验反应呈阳性的患者进行激发试验。在1001次激发试验中,136例(13%)患者出现了阳性激发反应。最常被怀疑的药物是抗菌药物,占激发试验的67%和阳性反应的66%。皮疹是最常见的皮肤反应(72%),其次是固定性药疹(16%)和荨麻疹(12%)。观察到1例使用柳氮磺胺吡啶的严重激发反应。我们得出结论,激发试验作为耐受性试验或排除药物超敏反应最为有用。如果没有其他诊断方法或其他诊断试验结果为阴性,对有皮疹病史的患者进行药物不良反应研究可能会有所帮助。大多数情况下可采用门诊方案。